The Global Robotic Biopsy Devices Industry is on track for a remarkable surge, fueled by advancements in technology and a growing need for accurate diagnoses. According to recent data, the market reached a valuation of US$440.2 million in 2023. Looking ahead, it is projected to climb at a robust Compound Annual Growth Rate (CAGR) of …